You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 300 No. 14, October 8, 2008 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related article
 •Related letters
 •Similar articles in JAMA
 Topic Collections
 •Bacterial Infections
 •Critical Care/ Intensive Care Medicine
 •Adult Critical Care
 •Pediatrics
 •Neonatology and Infant Care
 •Screening
 •Drug Therapy
 •Drug Therapy, Other
 •Infectious Diseases
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Reductions in Incidence of Invasive Group B Streptococcal Disease in the United States

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: The study by Dr Phares and colleagues1 concluded that there was an overall reduction in the incidence of group B streptococcal disease in neonates within the first 6 days of life for the period 2003 to 2005 compared with 1999 to 2001. This decrease coincided with revised disease prevention guidelines in 2002. The study shows a reduction only in the number of positive cerebrospinal fluid and blood cultures. However, the rate of positive cultures is not an accurate and exclusive measure of the incidence of invasive streptococcal disease. This study's approach is particularly problematic for assessing the epidemiology of early onset sepsis.

Using positive cultures as a required criterion is likely to underestimate the prevalence of neonatal early onset sepsis because results are affected by small sample volumes,2-3 significant sampling errors4 and the presence of antibiotics.5 Based on this, clinicians have developed the concept of suspected sepsis, . . . [Full Text of this Article]

Ralph K. H. Nanan, PhD, FRACP
ralphn@med.usyd.edu.au

Gurvinder Singh, MBBS; Alison Poulton, MBBChir, MRCP, FRACP
Nepean Clinical School
University of Sydney
Penrith, Australia



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Epidemiology of Invasive Group B Streptococcal Disease in the United States, 1999-2005
Christina R. Phares, Ruth Lynfield, Monica M. Farley, Janet Mohle-Boetani, Lee H. Harrison, Susan Petit, Allen S. Craig, William Schaffner, Shelley M. Zansky, Ken Gershman, Karen R. Stefonek, Bernadette A. Albanese, Elizabeth R. Zell, Anne Schuchat, and Stephanie J. Schrag
JAMA. 2008;299(17):2056-2065.
ABSTRACT | FULL TEXT  

RELATED LETTERS

Reductions in Incidence of Invasive Group B Streptococcal Disease in the United States
Clyde Mitchell
JAMA. 2008;300(14):1649.
EXTRACT | FULL TEXT  

Reductions in Incidence of Invasive Group B Streptococcal Disease in the United States—Reply
Christina Phares, Anne Schuchat, and Stephanie Schrag
JAMA. 2008;300(14):1650.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.